Consistent with this hypothesis, our data demonstrate that blocking hepcidin up-regulation in Tmprss6−/−mice via anti-HJV therapy, completely reverted hepatic steatosis resistance in matriptase-2 deficient mice. Here, TMPRSS6 is linked to fatty liver disease.